57. Developing oncogenicity guidelines for BCR::ABL1-like B-lymphoblastic leukemia/lymphoma through expert consensus
Year: 2024
Type: article
Source: Cancer Genetics
Authors: Kilannin Krysiak, Jason Saliba, Chimène Kesserwan, Yassmine Akkari, Mark D. Ewalt, Ilaria Iacobucci, Paulo Campregher, Paul G. Ekert, Deepa Bhojwani, Laura B. Corson, Nikita Mehta, Shivani Golem, Rashmi Kanagal-Shamanna, Alexandra E. Kovach, Kristy Lee, Arpad Danos, Hannah Helber, Sandeep Gurbuxani, Christine J. Harrison, Nitin Jain, Valentina Nardi, Shalini C. Reshmi, Morteza Seifi, Kathryn Roberts, Alexandre Rouette, Neerav Shukla, Wendy Stock, Xinjie Xu, Liying Zhang, Yiming Zhong, Xiaonan Zhao, Linda B. Baughn, Panieh Terraf, Obi L. Griffith, Malachi Griffith, Gordana Raca, Mark G. Evans, Charles Mullighan
Institutions: Washington University in St. Louis, New York University, Nationwide Children's Hospital, Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital, Hospital Israelita Albert Einstein, Peter MacCallum Cancer Centre, UNSW Sydney, Children's Hospital of Los Angeles, University of Kansas Medical Center, The University of Texas MD Anderson Cancer Center, Sema4 (United States), Baylor College of Medicine, Texas Children's Hospital, University of Chicago, Newcastle University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402855239
